Advanced search
Publication Cover
Journal of Enzyme Inhibition and Medicinal Chemistry Volume 34, 2019 - Issue 1
Submit an article Journal homepage
2,583
Views
62
CrossRef citations to date
0
Altmetric
Research Paper

Synthesis and in vitro anticancer activity of certain novel 1-(2-methyl-6-arylpyridin-3-yl)-3-phenylureas as apoptosis-inducing agents

Wagdy M. EldehnaDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt; View further author information
,
Ghada S. HassanDepartment of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt; View further author information
,
Sara T. Al-RashoodDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; Correspondence[email protected]
View further author information
,
Tarfah Al-WarhiDepartment of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia; View further author information
,
Ahmed E. AltyarDepartment of Clinical Pharmacy, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; ORCID Iconhttp://orcid.org/0000-0001-6210-3628View further author information
ORCID Icon,
Hamad M. AlkahtaniDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; View further author information
,
Abdulrahman A. AlmehiziaDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; ORCID Iconhttp://orcid.org/0000-0001-8711-3873View further author information
ORCID Icon &
Hatem A. Abdel-AzizDepartment of Applied Organic Chemistry, National Research Center, Cairo, EgyptView further author information
 show all
Pages 322-332 | Received 16 Oct 2018, Accepted 08 Nov 2018, Published online: 05 Feb 2019

Citations (62)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (18)

Eman A. Sobh, Mohammed A. Dahab, Eslam B. Elkaeed, Aisha A. Alsfouk, Ibrahim M. Ibrahim, Ahmed M. Metwaly & Ibrahim H. Eissa. (2023) Design, synthesis, docking, MD simulations, and anti-proliferative evaluation of thieno[2,3-d]pyrimidine derivatives as new EGFR inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Mohammed A. Dahab, Hazem A. Mahdy, Hazem Elkady, Mohammed S. Taghour, Alaa Elwan, Mohamed A. Elkady, Elsayed G. E. Elsakka, Eslam B. Elkaeed, Aisha A. Alsfouk, Ibrahim M. Ibrahim, Ahmed M. Metwaly & Ibrahim H. Eissa. (2023) Semi-synthesized anticancer theobromine derivatives targeting VEGFR-2: in silico and in vitro evaluations. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-20.
Read now
Eman A. Sobh, Mohammed A. Dahab, Eslam B. Elkaeed, Aisha A. Alsfouk, Ibrahim M. Ibrahim, Ahmed M. Metwaly & Ibrahim H. Eissa. (2023) Computer aided drug discovery (CADD) of a thieno[2,3-d]pyrimidine derivative as a new EGFR inhibitor targeting the ribose pocket. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-23.
Read now
Ahmed A. Gaber, Mohamed Sobhy, Abdallah Turky, Hanan Gaber Abdulwahab, Ahmed A. Al-Karmalawy, Mostafa. A. Elhendawy, Mohamed. M. Radwan, Eslam B. Elkaeed, Ibrahim M. Ibrahim, Heba S. A. Elzahabi & Ibrahim H. Eissa. (2022) Discovery of new 1H-pyrazolo[3,4-d]pyrimidine derivatives as anticancer agents targeting EGFRWT and EGFRT790M. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 2283-2303.
Read now
Reda G. Yousef, Alaa Elwan, Ibraheem M. M. Gobaara, Ahmed B. M. Mehany, Wagdy M. Eldehna, Souad A. El-Metwally, Bshra A. Alsfouk, Eslam B. Elkaeed, Ahmed M. Metwaly & Ibrahim H. Eissa. (2022) Anti-cancer and immunomodulatory evaluation of new nicotinamide derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: in vitro and in silico studies. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 2206-2222.
Read now
Mohammed S. Taghour, Hazem A. Mahdy, Maher H. Gomaa, Ahmed Aglan, Mahmoud Gomaa Eldeib, Alaa Elwan, Mohammed A. Dahab, Eslam B. Elkaeed, Aisha A. Alsfouk, Mohamed M. Khalifa, Ibrahim H. Eissa & Hazem Elkady. (2022) Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 2063-2077.
Read now
Heba S. A. Elzahabi, Eman S. Nossier, Rania A. Alasfoury, May El-Manawaty, Sara M. Sayed, Eslam B. Elkaeed, Ahmed M. Metwaly, Mohamed Hagras & Ibrahim H. Eissa. (2022) Design, synthesis, and anti-cancer evaluation of new pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as potential EGFRWT and EGFRT790M inhibitors and apoptosis inducers. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 1053-1076.
Read now
Moustafa O. Aboelez, Amany Belal, Guangya Xiang & Xiang Ma. (2022) Design, synthesis, and molecular docking studies of novel pomalidomide-based PROTACs as potential anti-cancer agents targeting EGFRWT and EGFRT790M. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 1196-1211.
Read now
Mohamed Hagras, Marwa A. Saleh, Rogy R. Ezz Eldin, Abdelrahman A. Abuelkhir, Emad Gamil Khidr, Ahmed A. El-Husseiny, Hesham A. El-Mahdy, Eslam B. Elkaeed & Ibrahim H. Eissa. (2022) 1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 386-402.
Read now
Mohammed M. Alanazi, Alaa Elwan, Nawaf A. Alsaif, Ahmad J. Obaidullah, Hamad M. Alkahtani, Abdulrahman A. Al-Mehizia, Sultan M. Alsubaie, Mohammed S. Taghour & Ibrahim H. Eissa. (2021) Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: design, synthesis, and in silico studies. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 1732-1750.
Read now
Nawaf A. Alsaif, Mohammed S. Taghour, Mohammed M. Alanazi, Ahmad J. Obaidullah, Abdulrahman A. Al-Mehizia, Manal M. Alanazi, Saleh Aldawas, Alaa Elwan & Hazem Elkady. (2021) Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as anticancer agents and apoptosis inducers. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 1093-1114.
Read now
Mohamed Hagras, Moshira A. El Deeb, Heba S. A. Elzahabi, Eslam B. Elkaeed, Ahmed B. M. Mehany & Ibrahim H. Eissa. (2021) Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 640-658.
Read now
Zainab M. Elsayed, Wagdy M. Eldehna, Marwa M. Abdel-Aziz, Mahmoud A. El Hassab, Eslam B. Elkaeed, Tarfah Al-Warhi, Hatem A. Abdel-Aziz, Sahar M. Abou-Seri & Eman R. Mohammed. (2021) Development of novel isatin–nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing–bacteria. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 384-392.
Read now
Wagdy M. Eldehna, Sara T. Al-Rashood, Tarfah Al-Warhi, Razan O. Eskandrani, Amal Alharbi & Ahmed M. El Kerdawy. (2021) Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 271-286.
Read now
Ahmed Sabt, Wagdy M. Eldehna, Tarfah Al-Warhi, Ohoud J. Alotaibi, Mahmoud M. Elaasser, Howayda Suliman & Hatem A. Abdel-Aziz. (2020) Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 1616-1630.
Read now
Tarfah Al-Warhi, Mahmoud F. Abo-Ashour, Hadia Almahli, Ohoud J. Alotaibi, Mohammad M. Al-Sanea, Ghada H. Al-Ansary, Hanaa Y. Ahmed, Mahmoud M. Elaasser, Wagdy M. Eldehna & Hatem A. Abdel-Aziz. (2020) Novel [(N-alkyl-3-indolylmethylene)hydrazono]oxindoles arrest cell cycle and induce cell apoptosis by inhibiting CDK2 and Bcl-2: synthesis, biological evaluation and in silico studies. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 1300-1309.
Read now
Sara T. Al-Rashood, Ahmed R. Hamed, Ghada S. Hassan, Hamad M. Alkahtani, Abdulrahman A. Almehizia, Amal Alharbi, Mohammad M. Al-Sanea & Wagdy M. Eldehna. (2020) Antitumor properties of certain spirooxindoles towards hepatocellular carcinoma endowed with antioxidant activity. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 831-839.
Read now
Mohamed A. Abdelrahman, Wagdy M. Eldehna, Alessio Nocentini, Hany S. Ibrahim, Hadia Almahli, Hatem A. Abdel-Aziz, Sahar M. Abou-Seri & Claudiu T. Supuran. (2020) Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in vitro biological evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 298-305.
Read now

Articles from other publishers (44)

Emilio Guillén-Mancina, María del Rosario García-Lozano, Estefanía Burgos-Morón, Sarah Mazzotta, Pablo Martínez-Aguado, José Manuel Calderón-Montaño, José Manuel Vega-Pérez, Miguel López-Lázaro, Fernando Iglesias-Guerra & Margarita Vega-Holm. (2023) Repurposing Study of 4-Acyl-1-phenylaminocarbonyl-2-substituted-piperazine Derivatives as Potential Anticancer Agents—In Vitro Evaluation against Breast Cancer Cells. International Journal of Molecular Sciences 24:23, pages 17041.
Crossref
Nitin Srivastava & Anil Kumar Saxena. (2023) Caspase-3 Activators as Anticancer Agents. Current Protein & Peptide Science 24:10, pages 783-804.
Crossref
Eman A. Sobh, Mohammed A. Dahab, Eslam B. Elkaeed, Bshra A. Alsfouk, Ibrahim M. Ibrahim, Ahmed M. Metwaly & Ibrahim H. Eissa. (2023) New thieno[2,3‐ d ]pyrimidine derivatives as EGFR WT and EGFR T790M inhibitors: Design, synthesis, antiproliferative activities, docking studies, ADMET , toxicity, MD simulation studies . Journal of Heterocyclic Chemistry.
Crossref
Kereyagalahally H. Narasimhamurthy, Nichhapurada Kallesha, Chakrabhavi D. Mohan & Kanchugarakoppal S. Rangappa. 2023. Cytotoxicity - Understanding Cellular Damage and Response. Cytotoxicity - Understanding Cellular Damage and Response.
Wagdy M. Eldehna, Eslam E. Mohammed, Ghada H. Al-Ansary, Emanuela Berrino, Mostafa M. Elbadawi, Tamer M. Ibrahim, Maiy Y. Jaballah, Sara T. Al-Rashood, Faizah A. Binjubair, Meltem Celik, Alessio Nocentini, Fawzy A. Elbarbry, Fikrettin Sahin, Hatem A. Abdel-Aziz, Claudiu T. Supuran & Mohamed Fares. (2023) Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer. European Journal of Medicinal Chemistry 258, pages 115538.
Crossref
Eman A. Sobh, Mohammed A. Dahab, Eslam B. Elkaeed, Bshra A. Alsfouk, Ibrahim M. Ibrahim, Ahmed M. Metwaly & Ibrahim H. Eissa. (2023) A novel thieno[2,3‐ d ]pyrimidine derivative inhibiting vascular endothelial growth factor receptor‐2: A story of computer‐aided drug discovery . Drug Development Research 84:6, pages 1247-1265.
Crossref
Mohammed M. Alanazi & Ashwag S. Alanazi. (2023) Novel 7-Deazapurine Incorporating Isatin Hybrid Compounds as Protein Kinase Inhibitors: Design, Synthesis, In Silico Studies, and Antiproliferative Evaluation. Molecules 28:15, pages 5869.
Crossref
Eman A Sobh, Mohammed A Dahab, Eslam B Elkaeed, Aisha A Alsfouk, Ibrahim M Ibrahim, Ahmed M Metwaly & Ibrahim H Eissa. (2023) Discovery of new thieno[2,3- d ]pyrimidines as EGFR tyrosine kinase inhibitors for cancer treatment . Future Medicinal Chemistry.
Crossref
Hazem A Mahdy, Hazem Elkady, Mohammed S Taghour, Alaa Elwan, Mohammed A Dahab, Mohamed A Elkady, Elsayed GE Elsakka, Eslam B Elkaeed, Bshra A Alsfouk, Ibrahim M Ibrahim, Ibrahim H Eissa & Ahmed M Metwaly. (2023) New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulations. Future Medicinal Chemistry.
Crossref
Omnia R. Elbatrawy, Mohamed Hagras, Moshira A. El Deeb, Fatimah Agili, Maghawry Hegazy, Ahmed A. El-Husseiny, Mahmoud Mohamed Mokhtar, Samy Y. Elkhawaga, Ibrahim H. Eissa & Samar El-Kalyoubi. (2023) Discovery of New Uracil and Thiouracil Derivatives as Potential HDAC Inhibitors. Pharmaceuticals 16:7, pages 966.
Crossref
Omnia R Elbatrawy, Moshira A El Deeb, Mohamed Hagras, Fatimah Agili, Maghawry Hegazy, Ahmed A El-Husseiny, Mohamed A Elkady, Ibrahim H Eissa & Samar El-Kalyoubi. (2023) New thiouracil derivatives as histone deacetylase inhibitors and apoptosis inducers: design, synthesis and anticancer evaluation. Future Medicinal Chemistry 15:12, pages 1019-1035.
Crossref
Mehak Saba Lone, Mohamad Mosa Mubarak, Syed Ayaz Nabi, Farhat Ramzan Wani, Shaista Amin, Sayima Nabi, Hadiya Amin Kantroo, Mohammed Samim, Syed Shafi, Shamim Ahmad, Zahoor Ahmad, Syed Ovais Rizvi & Kalim Javed. (2023) Isonicotinoyl-butanoic acid hydrazone derivatives as anti-tubercular agents: In-silico studies, synthesis, spectral characterization and biological evaluation. Medicinal Chemistry Research 32:5, pages 808-826.
Crossref
Iman A. Y. Ghannam, Ahmed M. El Kerdawy, Marwa M. Mounier, Mahmoud T. Abo‐elfadl & Islam H. Ali. (2022) Novel 2‐oxo‐2‐phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR‐2 inhibitors: Design, synthesis, and anticancer evaluation. Archiv der Pharmazie 356:2.
Crossref
Ahmed A. Gaber, Mohamed Sobhy, Abdallah Turky, Wagdy M. Eldehna, Samiha A. El-Sebaey, Souad A. El-Metwally, Abeer M. El-Naggar, Ibrahim M. Ibrahim, Eslam B. Elkaeed, Ahmed M. Metwaly & Ibrahim H. Eissa. (2023) New [1,2,4]triazolo[4,3-c]quinazolines as intercalative Topo II inhibitors: Design, synthesis, biological evaluation, and in silico studies. PLOS ONE 18:1, pages e0274081.
Crossref
Ahmed A. Al-Karmalawy, Mohamed S. Nafie, Moataz A. Shaldam, Ayman Abo Elmaaty, Samar A. Antar, Anwar A. El-Hamaky, Mohamed A. Saleh, Ahmed Elkamhawy & Haytham O. Tawfik. (2022) Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations. Journal of Medicinal Chemistry 66:1, pages 777-792.
Crossref
Eman S. Nossier, Rania A. Alasfoury, Mohamed Hagras, May El-Manawaty, Sara M. Sayed, Ibrahim M. Ibrahim, Hazem Elkady, Ibrahim H. Eissa & Heba S.A. Elzahabi. (2022) Modified pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as EGFRWT and EGFRT790M inhibitors: Design, synthesis, and anti-cancer evaluation. Journal of Molecular Structure 1270, pages 133971.
Crossref
Ahmed K.B.A.W. Farouk, Heba Abdelrasheed Allam, Essam Rashwan, Riham F. George & Safinaz E-S. Abbas. (2022) Design and synthesis of some new 6-bromo-2-(pyridin-3-yl)-4-substituted quinazolines as multi tyrosine kinase inhibitors. Bioorganic Chemistry 128, pages 106099.
Crossref
Eslam B. Elkaeed, Reda G. Yousef, Mohamed M. Khalifa, Albaraa Ibrahim, Ahmed B. M. Mehany, Ibraheem M. M. Gobaara, Bshra A. Alsfouk, Wagdy M. Eldehna, Ahmed M. Metwaly, Ibrahim H. Eissa & Mohamed Ayman El-Zahabi. (2022) Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies. Molecules 27:19, pages 6203.
Crossref
Eurico Lima, Andreia G. Barroso, Margarida A. Sousa, Octávio Ferreira, Renato E. Boto, José R. Fernandes, Paulo Almeida, Samuel M. Silvestre, Adriana O. Santos & Lucinda V. Reis. (2022) Picolylamine-functionalized benz[e]indole squaraine dyes: Synthetic approach, characterization and in vitro efficacy as potential anticancer phototherapeutic agents. European Journal of Medicinal Chemistry 229, pages 114071.
Crossref
Nawaf A. Alsaif, Hazem A. Mahdy, Mohammed M. Alanazi, Ahmad J. Obaidullah, Hamad M. Alkahtani, Abdullah M. Al‐Hossaini, Abdulrahman A. Al‐Mehizi, Alaa Elwan & Mohammed S. Taghour. (2021) Targeting VEGFR‐2 by new quinoxaline derivatives: Design, synthesis, antiproliferative assay, apoptosis induction, and in silico studies. Archiv der Pharmazie 355:2.
Crossref
Reham F. Barghash, Wagdy M. Eldehna, Markéta Kovalová, Veronika Vojáčková, Vladimír Kryštof & Hatem A. Abdel-Aziz. (2022) One-pot three-component synthesis of novel pyrazolo[3,4-b]pyridines as potent antileukemic agents. European Journal of Medicinal Chemistry 227, pages 113952.
Crossref
Mohamed Hagras, Asmaa A. Mandour, Esraa A. Mohamed, Eslam B. Elkaeed, Ibrahim M. M. Gobaara, Ahmed B. M. Mehany, Nasser S. M. Ismail & Hanan M. Refaat. (2021) Design, synthesis, docking study and anticancer evaluation of new trimethoxyphenyl pyridine derivatives as tubulin inhibitors and apoptosis inducers. RSC Advances 11:63, pages 39728-39741.
Crossref
Mohammed M. Alanazi, Hazem Elkady, Nawaf A. Alsaif, Ahmad J. Obaidullah, Hamad M. Alkahtani, Manal M. Alanazi, Madhawi A. Alharbi, Ibrahim H. Eissa & Mohammed A. Dahab. (2021) New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies . RSC Advances 11:48, pages 30315-30328.
Crossref
Nawaf A. Alsaif, Mohammed S. Taghour, Mohammed M. Alanazi, Ahmad J. Obaidullah, Wael A. Alanazi, Abdullah Alasmari, Hussam Albassam, Mohammed A. Dahab & Hazem A. Mahdy. (2021) Identification of new [1,2,4]triazolo[4,3-a]quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, anticancer evaluation, and in silico studies. Bioorganic & Medicinal Chemistry 46, pages 116384.
Crossref
Poonam Yadav, Ramakant Yadav, Shweta Jain & Ankur Vaidya. (2021) Caspase‐3: A primary target for natural and synthetic compounds for cancer therapy. Chemical Biology & Drug Design 98:1, pages 144-165.
Crossref
Mohammed M. Alanazi, Hazem A. Mahdy, Nawaf A. Alsaif, Ahmad J. Obaidullah, Hamad M. Alkahtani, Abdulrahman A. Al-Mehizia, Sultan M. Alsubaie, Mohammed A. Dahab & Ibrahim H. Eissa. (2021) New bis([1,2,4]triazolo)[4,3-a:3′,4′-c]quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation. Bioorganic Chemistry 112, pages 104949.
Crossref
Mostafa M. Elbadawi, Wagdy M. Eldehna, Alessio Nocentini, Mahmoud F. Abo-Ashour, Eslam B. Elkaeed, Mohamed A. Abdelgawad, Khalid S. Alharbi, Hatem A. Abdel-Aziz, Claudiu T. Supuran, Paola Gratteri & Mohammad M. Al-Sanea. (2021) Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: Synthesis and evaluation of the carbonic anhydrase inhibitory activities. European Journal of Medicinal Chemistry 218, pages 113360.
Crossref
Nawaf A. Alsaif, Mohammed A. Dahab, Mohammed M. Alanazi, Ahmad J. Obaidullah, Abdulrahman A. Al-Mehizia, Manal M. Alanazi, Saleh Aldawas, Hazem A. Mahdy & Hazem Elkady. (2021) New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis. Bioorganic Chemistry 110, pages 104807.
Crossref
Wagdy M. Eldehna, Mahmoud A. El Hassab, Mahmoud F. Abo-Ashour, Tarfah Al-Warhi, Mahmoud M. Elaasser, Nesreen A. Safwat, Howayda Suliman, Marwa F. Ahmed, Sara T. Al-Rashood, Hatem A. Abdel-Aziz & Radwan El-Haggar. (2021) Development of isatin-thiazolo[3,2-a]benzimidazole hybrids as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological and molecular dynamics investigations. Bioorganic Chemistry 110, pages 104748.
Crossref
Mostafa M. Elbadawi, Wagdy M. Eldehna, Wenjie Wang, Keli K. Agama, Yves Pommier & Manabu Abe. (2021) Discovery of 4-alkoxy-2-aryl-6,7-dimethoxyquinolines as a new class of topoisomerase I inhibitors endowed with potent in vitro anticancer activity. European Journal of Medicinal Chemistry 215, pages 113261.
Crossref
Eman A. Fayed, Ashraf H. Bayoumi, Aya S. Saleh, Elham M. Ezz Al-Arab & Yousry A. Ammar. (2021) In vivo and in vitro anti-inflammatory, antipyretic and ulcerogenic activities of pyridone and chromenopyridone derivatives, physicochemical and pharmacokinetic studies. Bioorganic Chemistry 109, pages 104742.
Crossref
Ibrahim.H. Eissa, Mohammed K. Ibrahim, Ahmed M. Metwaly, Amany Belal, Ahmed B.M. Mehany, Alsayed A. Abdelhady, Mostafa A. Elhendawy, Mohamed M. Radwan, Mahmoud A. ElSohly & Hazem A. Mahdy. (2021) Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma. Bioorganic Chemistry 107, pages 104532.
Crossref
Ahmed M. Abdel-Megied, Wagdy M. Eldehna, Mohamed A. Abdelrahman & Fawzy A. Elbarbry. (2020) Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma. Molecules 25:23, pages 5753.
Crossref
Eslam M. Abbass, Ali Kh. Khalil, Mohamed M. Mohamed, Ibrahim H. Eissa & Abeer M. El-Naggar. (2020) Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers. Bioorganic Chemistry 104, pages 104255.
Crossref
Mohamed Ayman El-Zahabi, Helmy Sakr, Khaled. El-Adl, Mohamed Zayed, Adel S. Abdelraheem, Sally I. Eissa, Hazem Elkady & Ibrahim H. Eissa. (2020) Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents. Bioorganic Chemistry 104, pages 104218.
Crossref
Mohd Adil Shareef, Ganthala Parimala Devi, Sunitha Rani Routhu, C. Ganesh Kumar, Ahmed Kamal & Bathini Nagendra Babu. (2020) New imidazo[2,1- b ]thiazole-based aryl hydrazones: unravelling their synthesis and antiproliferative and apoptosis-inducing potential . RSC Medicinal Chemistry 11:10, pages 1178-1184.
Crossref
Ahmed A. Nasser, Ibrahim H. Eissa, Mohamed R. Oun, Mohamed A. El-Zahabi, Mohammed S. Taghour, Amany Belal, Abdulrahman M. Saleh, Ahmed B. M. Mehany, Hendrik Luesch, Ahmad E. Mostafa, Wael M. Afifi, James R. Rocca & Hazem A. Mahdy. (2020) Discovery of new pyrimidine-5-carbonitrile derivatives as anticancer agents targeting EGFR WT and EGFR T790M . Organic & Biomolecular Chemistry 18:38, pages 7608-7634.
Crossref
Khaled R.A. Abdellatif, Amany Belal, Mohamed T. El-Saadi, Noha H. Amin, Eman G. Said & Loah R. Hemeda. (2020) Design, synthesis, molecular docking and antiproliferative activity of some novel benzothiazole derivatives targeting EGFR/HER2 and TS. Bioorganic Chemistry 101, pages 103976.
Crossref
Mohammad M. Al-Sanea, Ahmed Elkamhawy, Sora Paik, Kyeong Lee, Ahmed M. El Kerdawy, Bukhari Syed Nasir Abbas, Eun Joo Roh, Wagdy M. Eldehna, Heba A.H. Elshemy, Rania B Bakr, Ibrahim Ali Farahat, Abdulaziz I. Alzarea, Sami I. Alzarea, Khalid S. Alharbi & Mohamed A. Abdelgawad. (2020) Sulfonamide-based 4-anilinoquinoline derivatives as novel dual Aurora kinase (AURKA/B) inhibitors: Synthesis, biological evaluation and in silico insights. Bioorganic & Medicinal Chemistry 28:13, pages 115525.
Crossref
Andrea Petreni, Alessandro Bonardi, Carrie Lomelino, Sameh M. Osman, Zeid A. ALOthman, Wagdy M. Eldehna, Radwan El-Haggar, Robert McKenna, Alessio Nocentini & Claudiu T. Supuran. (2020) Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells. European Journal of Medicinal Chemistry 190, pages 112112.
Crossref
Mohamed A. Said, Wagdy M. Eldehna, Alessio Nocentini, Samar H. Fahim, Alessandro Bonardi, Abdullah A. Elgazar, Vladimír Kryštof, Dalia H. Soliman, Hatem A. Abdel-Aziz, Paola Gratteri, Sahar M. Abou-Seri & Claudiu T. Supuran. (2020) Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation. European Journal of Medicinal Chemistry 189, pages 112019.
Crossref
Mahmoud F. Abo-Ashour, Wagdy M. Eldehna, Alessio Nocentini, Alessandro Bonardi, Silvia Bua, Hany S. Ibrahim, Mahmoud M. Elaasser, Vladimír Kryštof, Radek Jorda, Paola Gratteri, Sahar M. Abou-Seri & Claudiu T. Supuran. (2019) 3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico insights. European Journal of Medicinal Chemistry 184, pages 111768.
Crossref
Wagdy M. Eldehna, Mohamed A. Abdelrahman, Alessio Nocentini, Silvia Bua, Sara T. Al-Rashood, Ghada S. Hassan, Alessandro Bonardi, Abdulrahman A. Almehizia, Hamad M. Alkahtani, Amal Alharbi, Paola Gratteri & Claudiu T. Supuran. (2019) Synthesis, biological evaluation and in silico studies with 4-benzylidene-2-phenyl-5(4H)-imidazolone-based benzenesulfonamides as novel selective carbonic anhydrase IX inhibitors endowed with anticancer activity. Bioorganic Chemistry 90, pages 103102.
Crossref
Mohamed A. Abdelrahman, Wagdy M. Eldehna, Alessio Nocentini, Silvia Bua, Sara T. Al-Rashood, Ghada S. Hassan, Alessandro Bonardi, Abdulrahman A. Almehizia, Hamad M. Alkahtani, Amal Alharbi, Paola Gratteri & Claudiu T. Supuran. (2019) Novel Diamide-Based Benzenesulfonamides as Selective Carbonic Anhydrase IX Inhibitors Endowed with Antitumor Activity: Synthesis, Biological Evaluation and In Silico Insights. International Journal of Molecular Sciences 20:10, pages 2484.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.